Agents for the Treatment of Heparin-Induced Thrombocytopenia
- 31 August 2010
- journal article
- review article
- Published by Elsevier BV in Hematology/Oncology Clinics of North America
- Vol. 24 (4), 755-775
- https://doi.org/10.1016/j.hoc.2010.05.009
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic strokeThrombosis and Haemostasis, 2010
- Fondaparinux for the Treatment of Acute Heparin-Induced Thrombocytopenia: A Single-Center ExperienceClinical and Applied Thrombosis/hemostasis, 2009
- Heparin‐induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery ‘spontaneous’ HITJournal of Thrombosis and Haemostasis, 2009
- Heparin‐independent activation of platelets by heparin‐induced thrombocytopenia antibodies: a common occurrenceJournal of Thrombosis and Haemostasis, 2008
- Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT)Thrombosis and Haemostasis, 2008
- Fondaparinux for the treatment of patients with acute heparininduced thrombocytopeniaThrombosis and Haemostasis, 2008
- Heparin-Induced Thrombocytopenia Associated with FondaparinuxThe New England Journal of Medicine, 2007
- Gender imbalance and risk factor interactions in heparin-induced thrombocytopeniaBlood, 2006
- Close Approximation of Two Platelet Factor 4 Tetramers by Charge Neutralization Forms the Antigens Recognized by HIT AntibodiesArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinThe New England Journal of Medicine, 1995